-
Posted by
Two Blokes Tue at 8:45 AM -
Filed in
Stock
-
2 views
Paris, France, May 13, 2025 (GLOBE NEWSWIRE) -- EG 427 announced today data highlighting the Company's leading role in developing non-replicating HSV-1 (nrHSV-1) vector technology in neurology. Data will be presented at the 28th Annual Meeting of the American Society of Cell and Gene Therapy (ASGCT), May 13-17, New Orleans.
